Fundz

Fundz Deep Dive

Everything you need to win TippingPoint Biosciences — in one platform.

Who to reach, what to say, and why now on TippingPoint Biosciences — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on TippingPoint Biosciences — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

TippingPoint Biosciences raised an undisclosed amount in Pre-Seed funding led by Pediatric Brain Tumor Foundation, Sontag Foundation, Yuvaan Tiwari Foundation, and BrightEdge to expand operations and development efforts.

PRIVATESep 05, 2024•almost 2 years ago

Round Type

seed

San FranciscoBiotechnologyHealth CareMedicalTherapeutics

Investors

Bright EdgeYuvaan Tiwari FoundationSontag FoundationPediatric Brain Tumor Foundation

Description

TippingPoint Biosciences, a San Francisco-based therapeutic company, has closed a Pre-Seed funding round. The funds will be used to expand operations and further develop its innovative drug discovery platform targeting aberrant DNA in cancer cells.

Company Information

Company

TippingPoint Biosciences

Location

San Francisco, California, United States

About

TippingPoint Biosciences is a San Francisco-based therapeutic company focused on innovative drug discovery targeting the aberrant DNA in cancer cells. Led by CEO Dr. Laura Hsieh, the company has developed a novel platform for identifying first-in-class drugs for diseases related to dysfunctional DNA packaging. Their screening platform aims to directly target defective chromatin in disease cells while preserving healthy cells. The technology has applications in several disease areas, including cancer and neurodegenerative diseases.

Related People

Suggested for you
1 contact

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for TippingPoint Biosciences's next move

Learn about Strategic plan

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.

Watching TippingPoint Biosciences? See every signal — funding, hires, M&A, contracts, sentiment.

Request a demoChoose your plan